Abstract
Gene rearrangements involving the Ewing sarcoma breakpoint region 1 (EWSR1) gene are seen in a broad range of sarcomas and some nonmesenchymal neoplasms. Ewing sarcoma is molecularly defined by a fusion of the EWSR1 gene (or rarely the related FUS gene) to a member of the E26 transformation-specific (ETS) family of transcription factors, frequently the EWSR1-FLI1 fusion. More recently, EWSR1 gene fusion to non-ETS family members, including the nuclear factor of activated T cells, cytoplasmic, calcineurin-dependent 2 (NFATC2) gene, has been reported in a histological variant of Ewing sarcoma. Here, we report a malignant round cell tumor of bone with an EWSR1-NFATC2 fusion gene. This report builds upon the unusual morphological and clinical presentation of bone neoplasms containing an EWSR1-NFATC2 fusion gene.
Similar content being viewed by others
References
Delattre O, Zucman J, Melot T et al (1994) The Ewing family of tumors—a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med 331:294–299. doi:10.1056/NEJM199408043310503
Sandberg AA, Bridge JA (2000) Updates on cytogenetics and molecular genetics of bone and soft tissue tumors: Ewing sarcoma and peripheral primitive neuroectodermal tumors. Cancer Genet Cytogenet 123:1–26
Delattre O, Zucman J, Plougastel B et al (1992) Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 359:162–165. doi:10.1038/359162a0
Sorensen PH, Lessnick SL, Lopez-Terrada D et al (1994) A second Ewing’s sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG. Nat Genet 6:146–151. doi:10.1038/ng0294-146
Jeon IS, Davis JN, Braun BS et al (1995) A variant Ewing’s sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1. Oncogene 10:1229–1234
Kaneko Y, Yoshida K, Handa M et al (1996) Fusion of an ETS-family gene, EIAF, to EWS by t(17;22)(q12;q12) chromosome translocation in an undifferentiated sarcoma of infancy. Genes Chromosome Cancer 15:115–121. doi:10.1002/(SICI)1098-2264(199602)15:2<115::AID-GCC6>3.0.CO;2-6
Peter M, Couturier J, Pacquement H et al (1997) A new member of the ETS family fused to EWS in Ewing tumors. Oncogene 14:1159–1164. doi:10.1038/sj.onc.1200933
May WA, Lessnick SL, Braun BS et al (1993) The Ewing’s sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1. Mol Cell Biol 13:7393–7398
Riggi N, Cironi L, Provero P et al (2005) Development of Ewing’s sarcoma from primary bone marrow-derived mesenchymal progenitor cells. Cancer Res 65:11459–11468. doi:10.1158/0008-5472.CAN-05-1696
Castillero-Trejo Y, Eliazer S, Xiang L et al (2005) Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells results in EWS/FLI-1-dependent, ewing sarcoma-like tumors. Cancer Res 65:8698–8705. doi:10.1158/0008-5472.CAN-05-1704
Robin TP, Smith A, McKinsey E et al (2012) EWS/FLI1 regulates EYA3 in Ewing sarcoma via modulation of miRNA-708, resulting in increased cell survival and chemoresistance. Mol Cancer Res 10:1098–1108. doi:10.1158/1541-7786.MCR-12-0086
Hu-Lieskovan S, Heidel JD, Bartlett DW et al (2005) Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing’s sarcoma. Cancer Res 65:8984–8992. doi:10.1158/0008-5472.CAN-05-0565
Lambert G, Bertrand JR, Fattal E et al (2000) EWS fli-1 antisense nanocapsules inhibits ewing sarcoma-related tumor in mice. Biochem Biophys Res Commun 279:401–406. doi:10.1006/bbrc.2000.3963
Mastrangelo T, Modena P, Tornielli S et al (2000) A novel zinc finger gene is fused to EWS in small round cell tumor. Oncogene 19:3799–3804. doi:10.1038/sj.onc.1203762
Wang L, Bhargava R, Zheng T et al (2007) Undifferentiated small round cell sarcomas with rare EWS gene fusions: identification of a novel EWS-SP3 fusion and of additional cases with the EWS-ETV1 and EWS-FEV fusions. J Mol Diagn 9:498–509. doi:10.2353/jmoldx.2007.070053
Sumegi J, Nishio J, Nelson M et al (2011) A novel t(4;22)(q31;q12) produces an EWSR1-SMARCA5 fusion in extraskeletal Ewing sarcoma/primitive neuroectodermal tumor. Mod Pathol Off J U S Can Acad Pathol Inc 24:333–342. doi:10.1038/modpathol.2010.201
Szuhai K, Ijszenga M, de Jong D et al (2009) The NFATc2 gene is involved in a novel cloned translocation in a Ewing sarcoma variant that couples its function in immunology to oncology. Clin Cancer Res Off J Am Assoc Cancer Res 15:2259–2268. doi:10.1158/1078-0432.CCR-08-2184
Ladanyi M, Gerald W (1994) Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor. Cancer Res 54:2837–2840
Zucman J, Delattre O, Desmaze C et al (1993) EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts. Nat Genet 4:341–345. doi:10.1038/ng0893-341
Rossi S, Szuhai K, Ijszenga M et al (2007) EWSR1-CREB1 and EWSR1-ATF1 fusion genes in angiomatoid fibrous histiocytoma. Clin Cancer Res Off J Am Assoc Cancer Res 13:7322–7328. doi:10.1158/1078-0432.CCR-07-1744
Panagopoulos I, Mertens F, Isaksson M et al (2002) Molecular genetic characterization of the EWS/CHN and RBP56/CHN fusion genes in extraskeletalmyxoidchondrosarcoma. Genes Chromosom Cancer 35:340–352. doi:10.1002/gcc.10127
Panagopoulos I, Höglund M, Mertens F et al (1996) Fusion of the EWS and CHOP genes in myxoidliposarcoma. Oncogene 12:489–494
Thway K, Nicholson AG, Lawson K et al (2011) Primary pulmonary myxoid sarcoma with EWSR1-CREB1 fusion: a new tumor entity. Am J SurgPathol 35:1722–1732. doi:10.1097/PAS.0b013e318227e4d2
Flucke U, Mentzel T, Verdijk MA et al (2012) EWSR1-ATF1 chimeric transcript in a myoepithelial tumor of soft tissue: a case report. Hum Pathol 43:764–768. doi:10.1016/j.humpath.2011.08.004
Antonescu CR, Zhang L, Chang N-E et al (2010) EWSR1-POU5F1 fusion in soft tissue myoepithelial tumors. A molecular analysis of sixty-six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the EWSR1 gene. Genes Chromosome Cancer 49:1114–1124
Fisher C (2014) The diversity of soft tissue tumours with EWSR1 gene rearrangements: a review. Histopathology 64:134–150. doi:10.1111/his.12269
Arbajian E, Magnusson L, Brosjö O et al (2013) A benign vascular tumor with a new fusion gene: EWSR1-NFATC1 in hemangioma of the bone. Am J Surg Pathol 37:613–616. doi:10.1097/PAS.0b013e31827ae13b
Antonescu CR, Katabi N, Zhang L et al (2011) EWSR1-ATF1 fusion is a novel and consistent finding in hyalinizing clear-cell carcinoma of salivary gland. Genes Chromosome Cancer 50:559–570. doi:10.1002/gcc.20881
Panagopoulos I, Thorsen J, Gorunova L et al (2013) RNA sequencing identifies fusion of the EWSR1 and YY1 genes in mesothelioma with t(14;22)(q32;q12). Genes Chromosome Cancer 52:733–740. doi:10.1002/gcc.22068
Möller E, Stenman G, Mandahl N et al (2008) POU5F1, encoding a key regulator of stem cell pluripotency, is fused to EWSR1 in hidradenoma of the skin and mucoepidermoid carcinoma of the salivary glands. J Pathol 215:78–86. doi:10.1002/path.2327
Antonescu C (2014) Round cell sarcomas beyond Ewing: emerging entities. Histopathology 64:26–37. doi:10.1111/his.12281
Romeo S, Bovée JVMG, Kroon HM et al (2012) Malignant fibrous histiocytoma and fibrosarcoma of bone: a re-assessment in the light of currently employed morphological, immunohistochemical and molecular approaches. Virchows Arch Int J Pathol 461:561–570. doi:10.1007/s00428-012-1306-z
Pack SD, Zhuang Z (2001) Fluorescence in situ hybridization : application in cancer research and clinical diagnostics. Methods Mol Med 50:35–50. doi:10.1385/1-59259-084-5:35
Folpe AL, Goldblum JR, Rubin BP et al (2005) Morphologic and immunophenotypic diversity in Ewing family tumors: a study of 66 genetically confirmed cases. Am J Surg Pathol 29:1025–1033
Cotterill SJ, Ahrens S, Paulussen M et al (2000) Prognostic factors in Ewing’s tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing’s Sarcoma Study Group. J Clin Oncol Off J Am Soc Clin Oncol 18:3108–3114
Klein MJ, Siegal GP (2006) Osteosarcoma: anatomic and histologic variants. Am J Clin Pathol 125:555–581. doi:10.1309/UC6K-QHLD-9LV2-KENN
Lee AF, Hayes MM, Lebrun D et al (2011) FLI-1 distinguishes Ewing sarcoma from small cell osteosarcoma and mesenchymalchondrosarcoma. Appl Immunohistochem Mol Morphol AIMM Off Publ Soc Appl Immunohistochem 19:233–238. doi:10.1097/PAI.0b013e3181fd6697
Debelenko LV, McGregor LM, Shivakumar BR et al (2011) A novel EWSR1-CREB3L1 fusion transcript in a case of small cell osteosarcoma. Genes Chromosome Cancer 50:1054–1062. doi:10.1002/gcc.20923
Noguera R, Navarro S, Triche TJ (1990) Translocation (11;22) in small cell osteosarcoma. Cancer Genet Cytogenet 45:121–124
Machado I, Alberghini M, Giner F et al (2010) Histopathological characterization of small cell osteosarcoma with immunohistochemistry and molecular genetic support. A study of 10 cases. Histopathology 57:162–167
Miser JS, Krailo MD, Tarbell NJ, et al. (2004) Treatment of metastatic Ewing’s sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children’s Cancer Group and Pediatric Oncology Group study. J Clin Oncol Off J Am Soc Clin Oncol 22:2873–2876. doi: 10.1200/JCO.2004.01.041
Sakamoto A, Iwamoto Y (2008) Current status and perspectives regarding the treatment of osteo-sarcoma: chemotherapy. Rev Recent Clin Trials 3:228–231
Szuhai K, Cleton-Jansen A-M, Hogendoorn PCW, Bovée JVMG (2012) Molecular pathology and its diagnostic use in bone tumors. Cancer Genet 205:193–204. doi:10.1016/j.cancergen.2012.04.001
Acknowledgments
The authors have no financial or commercial obligations to disclose.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Sadri, N., Barroeta, J., Pack, S.D. et al. Malignant round cell tumor of bone with EWSR1-NFATC2 gene fusion. Virchows Arch 465, 233–239 (2014). https://doi.org/10.1007/s00428-014-1613-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00428-014-1613-7